AAAAAA

   
Results: 1-13 |
Results: 13
INHIBITION OF HIV-1 REPLICATION BY COMBINED EXPRESSION OF GAG DOMINANT-NEGATIVE MUTANT AND A HUMAN RIBONUCLEASE IN A TIGHTLY CONTROLLED HIV-1 INDUCIBLE VECTOR
Authors: CARA A RYBAK SM NEWTON DL CROWLEY R ROTTSCHAFER SE REITZ MS GUSELLA GL
Citation: A. Cara et al., INHIBITION OF HIV-1 REPLICATION BY COMBINED EXPRESSION OF GAG DOMINANT-NEGATIVE MUTANT AND A HUMAN RIBONUCLEASE IN A TIGHTLY CONTROLLED HIV-1 INDUCIBLE VECTOR, Gene therapy, 5(1), 1998, pp. 65-75
QUICK FIXES NO BARGAIN
Authors: NEWTON DL
Citation: Dl. Newton, QUICK FIXES NO BARGAIN, Civil engineering, 68(9), 1998, pp. 38-39
SINGLE AMINO-ACID SUBSTITUTIONS AT THE N-TERMINUS OF A RECOMBINANT CYTOTOXIC RIBONUCLEASE MARKEDLY INFLUENCE BIOCHEMICAL AND BIOLOGICAL PROPERTIES
Authors: NEWTON DL BOQUE L WLODAWER A HUANG CY RYBAK SM
Citation: Dl. Newton et al., SINGLE AMINO-ACID SUBSTITUTIONS AT THE N-TERMINUS OF A RECOMBINANT CYTOTOXIC RIBONUCLEASE MARKEDLY INFLUENCE BIOCHEMICAL AND BIOLOGICAL PROPERTIES, Biochemistry, 37(15), 1998, pp. 5173-5183
ESTABLISHING GUIDANCE FOR THE HANDLING AND CONTAINMENT OF NEW CHEMICAL ENTITIES AND CHEMICAL INTERMEDIATES IN THE PHARMACEUTICAL-INDUSTRY
Authors: OLSON MJ BINKS SP NEWTON DL CLARK GC
Citation: Mj. Olson et al., ESTABLISHING GUIDANCE FOR THE HANDLING AND CONTAINMENT OF NEW CHEMICAL ENTITIES AND CHEMICAL INTERMEDIATES IN THE PHARMACEUTICAL-INDUSTRY, Occupational medicine, 12(1), 1997, pp. 49-65
EXPRESSION AND CHARACTERIZATION OF A CYTOTOXIC HUMAN-FROG CHIMERIC RIBONUCLEASE - POTENTIAL FOR CANCER-THERAPY
Authors: NEWTON DL XUE Y BOQUE L WLODAWER A KUNG HF RYBAK SM
Citation: Dl. Newton et al., EXPRESSION AND CHARACTERIZATION OF A CYTOTOXIC HUMAN-FROG CHIMERIC RIBONUCLEASE - POTENTIAL FOR CANCER-THERAPY, Protein engineering, 10(4), 1997, pp. 463-470
ENHANCEMENT OF VINCRISTINE CYTOTOXICITY IN DRUG-RESISTANT CELLS BY SIMULTANEOUS TREATMENT WITH ONCONASE, AN ANTITUMOR RIBONUCLEASE
Authors: RYBAK SM PEARSON JW FOGLER WE VOLKER K SPENCE SE NEWTON DL MIKULSKI SM ARDELT W RIGGS CW KUNG HF LONGO DL
Citation: Sm. Rybak et al., ENHANCEMENT OF VINCRISTINE CYTOTOXICITY IN DRUG-RESISTANT CELLS BY SIMULTANEOUS TREATMENT WITH ONCONASE, AN ANTITUMOR RIBONUCLEASE, Journal of the National Cancer Institute, 88(11), 1996, pp. 747-753
ANTITUMOR RIBONUCLEASE, COMBINED WITH OR CONJUGATED TO MONOCLONAL-ANTIBODY MRK16, OVERCOMES MULTIDRUG-RESISTANCE TO VINCRISTINE IN-VITRO AND IN-VIVO
Authors: NEWTON DL PEARSON JW XUE Y SMITH MR FOGLER WE MIKULSKI SM ALVORD WG KUNG HF LONG DL RYBAK SM
Citation: Dl. Newton et al., ANTITUMOR RIBONUCLEASE, COMBINED WITH OR CONJUGATED TO MONOCLONAL-ANTIBODY MRK16, OVERCOMES MULTIDRUG-RESISTANCE TO VINCRISTINE IN-VITRO AND IN-VIVO, International journal of oncology, 8(6), 1996, pp. 1095-1104
X-RAY CRYSTALLOGRAPHIC STRUCTURE OF RECOMBINANT EOSINOPHIL-DERIVED NEUROTOXIN AT 1.83-ANGSTROM RESOLUTION
Authors: MOSIMANN SC NEWTON DL YOULE RJ JAMES MNG
Citation: Sc. Mosimann et al., X-RAY CRYSTALLOGRAPHIC STRUCTURE OF RECOMBINANT EOSINOPHIL-DERIVED NEUROTOXIN AT 1.83-ANGSTROM RESOLUTION, Journal of Molecular Biology, 260(4), 1996, pp. 540-552
ANGIOGENIN SINGLE-CHAIN IMMUNOFUSIONS - INFLUENCE OF PEPTIDE LINKERS AND SPACERS BETWEEN FUSION PROTEIN DOMAINS
Authors: NEWTON DL XUE Y OLSON KA FETT JW RYBAK SM
Citation: Dl. Newton et al., ANGIOGENIN SINGLE-CHAIN IMMUNOFUSIONS - INFLUENCE OF PEPTIDE LINKERS AND SPACERS BETWEEN FUSION PROTEIN DOMAINS, Biochemistry, 35(2), 1996, pp. 545-553
IN-VITRO ANTITUMOR-ACTIVITY OF THE PLANT RIBOSOME-INACTIVATING PROTEINS MAP-30 AND GAP-31
Authors: RYBAK SM LIN JJ NEWTON DL KUNG HF MONKS A CHEN HC HUANG PL LEEHUANG S
Citation: Sm. Rybak et al., IN-VITRO ANTITUMOR-ACTIVITY OF THE PLANT RIBOSOME-INACTIVATING PROTEINS MAP-30 AND GAP-31, International journal of oncology, 5(5), 1994, pp. 1171-1176
TOXICITY OF AN ANTITUMOR RIBONUCLEASE TO PURKINJE NEURONS
Authors: NEWTON DL WALBRIDGE S MIKULSKI SM ARDELT W SHOGEN K ACKERMAN SJ RYBAK SM YOULE RJ
Citation: Dl. Newton et al., TOXICITY OF AN ANTITUMOR RIBONUCLEASE TO PURKINJE NEURONS, The Journal of neuroscience, 14(2), 1994, pp. 538-544
EXPRESSION AND CHARACTERIZATION OF RECOMBINANT HUMAN EOSINOPHIL-DERIVED NEUROTOXIN AND EOSINOPHIL-DERIVED NEUROTOXIN-ANTI-TRANSFERRIN RECEPTOR SFV
Authors: NEWTON DL NICHOLLS PJ RYBAK SM YOULE RJ
Citation: Dl. Newton et al., EXPRESSION AND CHARACTERIZATION OF RECOMBINANT HUMAN EOSINOPHIL-DERIVED NEUROTOXIN AND EOSINOPHIL-DERIVED NEUROTOXIN-ANTI-TRANSFERRIN RECEPTOR SFV, The Journal of biological chemistry, 269(43), 1994, pp. 26739-26745
CHARACTERIZATION OF THE MECHANISM OF CELLULAR AND CELL-FREE PROTEIN-SYNTHESIS INHIBITION BY AN ANTITUMOR RIBONUCLEASE
Authors: LIN JJ NEWTON DL MIKULSKI SM KUNG HF YOULE RJ RYBAK SM
Citation: Jj. Lin et al., CHARACTERIZATION OF THE MECHANISM OF CELLULAR AND CELL-FREE PROTEIN-SYNTHESIS INHIBITION BY AN ANTITUMOR RIBONUCLEASE, Biochemical and biophysical research communications, 204(1), 1994, pp. 156-162
Risultati: 1-13 |